Interparfums Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of |
|
Commission |
|
(I.R.S. Employer |
(Address of Principal Executive Offices)
(Registrant’s Telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange |
|
|
|
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Certain portions of our press release dated October 21, 2024, a copy which is annexed hereto as Exhibit No. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:
- The 1st through 8th, and 10th full paragraphs relating to net sales for the third quarter or nine (9) months ended September 30, 2024
- Portions of the 9th, 11th and 12th paragraph relating to net sales for the third quarter or nine (9) months ended September 30, 2024
- The 14th-17th paragraphs relating to plans to release the third quarter and nine (9) months ended September 30, 2024 results and the 2024 third quarter conference call
Item 7.01 Regulation FD Disclosure
Certain portions of our press release dated October 21, 2024, a copy which is annexed hereto as Exhibit No. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulations FD. They are as follows:
- Portion of the 9th paragraph relating to future net sales for Donna Karan/DKNY
- Portion of the 11th paragraph relating to Roberto Cavalli products for the holiday 2024 season
- Portion of the 12th paragraph relating to future market share gain
- The 13th paragraph relating to reaffirming 2024 guidance and plans to issue initial 2025 guidance
- The 14th paragraph relating to our plans to issue our results for the third quarter and nine (9) months ended September 30, 2024 and the conference call scheduled for November 7, 2024
- The 20th paragraph relating to forward looking information
- The balance of such press release not otherwise incorporated by reference in Item 2.02
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.
Dated: October 21, 2024
|
Inter Parfums, Inc. | |
|
| |
|
By: |
/s/ Michel Atwood |
|
|
Michel Atwood |
|
|
Chief Financial Officer |